search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
infection control & hospital epidemiology july 2018, vol. 39, no. 7 original article


Assessing a National Collaborative Program To Prevent Catheter-Associated Urinary Tract Infection in a Veterans Health Administration Nursing Home Cohort


Sarah L. Krein, PhD, RN;1,3 M. Todd Greene, PhD, MPH;1,3 Beth King, RN, BSN, MA, CCM;5 Deborah Welsh, MS;5


Karen E. Fowler, MPH;1 BarbaraW. Trautner, MD, PhD;6,7 David Ratz, MS;1 Sanjay Saint, MD, MPH;1,3 Gary Roselle,MD;8 Marla Clifton, RN, MSN, CIC;8 StephenM.Kralovic,MD,MPH;8,9,10 Tina Martin, RN;11 Lona Mody,MD,MSc2,4


objective. Collaborative programs have helped reduce catheter-associated urinary tract infection (CAUTI) rates in community-based nursing homes. We assessed whether collaborative participation produced similar benefits among Veterans Health Administration (VHA) nursing homes, which are part of an integrated system.


setting. This study included 63 VHA nursing homes enrolled in the “AHRQ Safety Program for Long-Term Care,” which focused on practices to reduce CAUTI.


methods. Changes in CAUTI rates, catheter utilization, and urine culture orders were assessed from June 2015 through May 2016. Multilevel mixed-effects negative binomial regression was used to derive incidence rate ratios (IRRs) representing changes over the 12-month program period.


results. There was no significant change in CAUTI among VHA sites, with a CAUTI rate of 2.26 per 1,000 catheter days at month 1 and a rate of 3.19 at month 12 (incidence rate ratio [IRR], 0.99; 95% confidence interval [CI], 0.67–1.44). Results were similar for catheter utilization rates, which were 11.02% at month 1 and 11.30% at month 12 (IRR, 1.02; 95% CI, 0.95–1.09). The numbers of urine cultures per 1,000 residents were 5.27 in month 1 and 5.31 in month 12 (IRR, 0.93; 95% CI, 0.82–1.05).


conclusions. No changes in CAUTI rates, catheter use, or urine culture orders were found during the program period. One potential reason was the relatively low baseline CAUTI rate, as compared with a cohort of community-based nursing homes. This low baseline rate is likely related to the VHA’s prior CAUTI prevention efforts. While broad-scale collaborative approaches may be effective in some settings, targeting higher-prevalence safety issues may be warranted at sites already engaged in extensive infection prevention efforts.


Infect Control Hosp Epidemiol 2018;39:820–825


Veterans Health Administration (VHA) nursing homes, also called community living centers, provide a range of services including skilled nursing, rehabilitation, psychiatric, dementia, hospice and palliative care.1VHAnursing homes play critical roles in meeting both post-acute and long-term care needs of veterans. However, as in community-based nursing homes,2 infection is a common complication among VHA nursing home residents.3 Estimates suggest that, on any given day, ~12% of the more than 1 million nursing home residents in the United States


may have an infection.2 The most common of these is urinary tract infection (UTI), followed by pneumonia. While a point prevalence assessment in 2007 found a lower infection rate (5.3%) among VHA nursing homes, the most common infection was also UTI, and the infection rate was closer to 11% among veteran residents with indwelling devices, such as urinary catheters.3 These estimates become even more concerning when the growing prevalence and risk of antimicrobial-resistant infections are taken into account.4–6


Affiliations: 1. Center for Clinical Management Research, Ann Arbor Veteran Affairs (VA) Healthcare System, Ann Arbor, Michigan; 2. Geriatric Research


Education and Clinical Center, Ann Arbor Veteran Affairs (VA) Healthcare System, Ann Arbor, Michigan; 3. Division of General Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; 4. Division of Geriatric and Palliative Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; 5. VA National Center for Patient Safety (NCPS), Ann Arbor, Michigan; 6. Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas; and; 7. Section of Health Services Research, Departments of Medicine and Surgery, Baylor College of Medicine, Houston, Texas; 8. VA National Infectious Diseases Service (NIDS), Washington, DC; 9. Cincinnati VA Medical Center, Cincinnati, Ohio; 10. Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio; 11. VA Inpatient Evaluation Center (IPEC), Cincinnati, Ohio; (skrein@umich.edu).


© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved. 0899-823X/2018/3907-0008. DOI: 10.1017/ice.2018.99 Received January 23, 2018; accepted April 5, 2018; electronically published May 10, 2018


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144